These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9016899)

  • 1. Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats.
    Cowley BD; Rupp JC; Muessel MJ; Gattone VH
    Am J Kidney Dis; 1997 Feb; 29(2):265-72. PubMed ID: 9016899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of disease progression in rats with inherited polycystic kidney disease.
    Cowley BD; Grantham JJ; Muessel MJ; Kraybill AL; Gattone VH
    Am J Kidney Dis; 1996 Jun; 27(6):865-79. PubMed ID: 8651252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats.
    Cowley BD; Ricardo SD; Nagao S; Diamond JR
    Kidney Int; 2001 Dec; 60(6):2087-96. PubMed ID: 11737583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal concentration of alpha-tocopherol: dependence on gender and lack of effect on polycystic kidney disease in Han:SPRD rats.
    Torres VE; Bengal RJ; Nickander KK; Grande JP; Low PA
    Am J Kidney Dis; 1998 Apr; 31(4):687-93. PubMed ID: 9531187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of paclitaxel on the progression of polycystic kidney disease in rodents.
    Martinez JR; Cowley BD; Gattone VH; Nagao S; Yamaguchi T; Kaneta S; Takahashi H; Grantham JJ
    Am J Kidney Dis; 1997 Mar; 29(3):435-44. PubMed ID: 9041221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of renal innervation to hypertension in rat autosomal dominant polycystic kidney disease.
    Gattone VH; Siqueira TM; Powell CR; Trambaugh CM; Lingeman JE; Shalhav AL
    Exp Biol Med (Maywood); 2008 Aug; 233(8):952-7. PubMed ID: 18480417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender hormones and the progression of experimental polycystic kidney disease.
    Stringer KD; Komers R; Osman SA; Oyama TT; Lindsley JN; Anderson S
    Kidney Int; 2005 Oct; 68(4):1729-39. PubMed ID: 16164649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease.
    Tao Y; Kim J; Faubel S; Wu JC; Falk SA; Schrier RW; Edelstein CL
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6954-9. PubMed ID: 15863619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal-dominant polycystic kidney disease in the rat.
    Cowley BD; Gudapaty S; Kraybill AL; Barash BD; Harding MA; Calvet JP; Gattone VH
    Kidney Int; 1993 Mar; 43(3):522-34. PubMed ID: 8455352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease.
    Turner CM; Ramesh B; Srai SK; Burnstock G; Unwin RJ
    Cells Tissues Organs; 2004; 178(3):168-79. PubMed ID: 15655334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor pathway in rats with autosomal dominant polycystic kidney disease.
    Nagao S; Kusaka M; Nishii K; Marunouchi T; Kurahashi H; Takahashi H; Grantham J
    J Am Soc Nephrol; 2005 Jul; 16(7):2052-62. PubMed ID: 15888569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
    Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
    Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azotemia and extrarenal manifestations in old female Han:SPRD (cy/+) rats.
    Kränzlin B; Schieren G; Gretz N
    Kidney Int; 1997 Apr; 51(4):1160-9. PubMed ID: 9083282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of renal failure in the Han: SPRD polycystic kidney rat.
    Zeier M; Pohlmeyer G; Deerberg F; Schönherr R; Ritz E
    Nephrol Dial Transplant; 1994; 9(12):1734-9. PubMed ID: 7708256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of [¹⁸F]PFH PET renography to predict future disease progression in a rat model of autosomal dominant polycystic kidney disease.
    Pathuri G; Hedrick AF; Awasthi V; Cowley BD; Gali H
    Nucl Med Biol; 2016 Jan; 43(1):1-5. PubMed ID: 26702780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease.
    Tao Y; Kim J; Schrier RW; Edelstein CL
    J Am Soc Nephrol; 2005 Jan; 16(1):46-51. PubMed ID: 15563559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease.
    Pey R; Bach J; Schieren G; Gretz N; Hafner M
    In Vitro Cell Dev Biol Anim; 1999; 35(10):571-9. PubMed ID: 10614866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat.
    Gile RD; Cowley BD; Gattone VH; O'Donnell MP; Swan SK; Grantham JJ
    Am J Kidney Dis; 1995 Sep; 26(3):501-7. PubMed ID: 7645559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTGF Is Expressed During Cystic Remodeling in the PKD/Mhm (cy/+) Rat Model for Autosomal-Dominant Polycystic Kidney Disease (ADPKD).
    Gauer S; Holzmann Y; Kränzlin B; Hoffmann SC; Gretz N; Hauser IA; Goppelt-Struebe M; Geiger H; Obermüller N
    J Histochem Cytochem; 2017 Dec; 65(12):743-755. PubMed ID: 29058957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.